SARS-CoV-2 infection clinical picture and outcomes in adults living with HIV: a cohort analysis.


Journal

The new microbiologica
ISSN: 1121-7138
Titre abrégé: New Microbiol
Pays: Italy
ID NLM: 9516291

Informations de publication

Date de publication:
Feb 2023
Historique:
received: 28 02 2023
accepted: 28 02 2023
entrez: 28 2 2023
pubmed: 1 3 2023
medline: 3 3 2023
Statut: ppublish

Résumé

Existing evidence about HIV and SARS-CoV-2 co-infection has, so far, yield conflicting results. Methods: This is a cohort, single center, clinical study aimed at identifying possible characteristics of PLWH that could correlate with the risk of acquiring SARS-CoV-2 and would influence the outcome. 155 cases of SARS-CoV-2 infection were compared with 307 PLWH who tested negative. No variable was associated with an increased risk of infection. SARS-CoV-2 PLWH were completely asymptomatic in 20.6% of cases. Factors associated with severe COVID-19 were age (P=0.001), diabetes (P=0.009) hypertension (P=0.004), cardiovascular disease (P=0.001) or an increasing number of chronic co-morbidities (P=0.002); only the first two variables retained statistical significance in a multivariable model. Only older age and a lower CD4 count were statistically associated with death in the multivariate model. Sixteen PLWH not included in the analysis were infected by SARS-Cov-2 after vaccination. In 4 cases the infection was completely asymptomatic, while in the remaining 12 cases the infection was mild and resembled a flu-like syndrome. Conclusions: No baseline characteristic defines patients at greater risk of SARS-CoV-2 infection. Older age and the presence of multi-comorbidities are risk factors for a severe clinical course. Lower CD4 counts correlate with a fatal outcome.

Identifiants

pubmed: 36853813

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

18-23

Auteurs

Franco Maggiolo (F)

Division of Infectious Diseases.
Unit of HIV related diseases and experimental therapies.

Laura Comi (L)

Division of Infectious Diseases.

Marco Arosio (M)

Biobanking Unit, Microbiology and Virology Laboratory.

Daniela Valenti (D)

Unit of HIV related diseases and experimental therapies.
FROM Foundation.

Davide Guarneri (D)

Biobanking Unit, Microbiology and Virology Laboratory.

Marco Rizzi (M)

Division of Infectious Diseases.

Annapaola Callegaro (A)

ASST Papa Giovanni XXIII, Laboratory Medicine ASST Bergamo Est, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH